Medallion Wealth Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Medallion Wealth Advisors's WST Position: Q3 2026 in Review
Medallion Wealth Advisors held its West Pharmaceutical (WST) position steady in Q3 2026 at 5 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #969.
Medallion Wealth Advisors first reported a position in WST in Q4 2024 and has held it in 8 quarters since. The position peaked at $35.2K in Q4 2025. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Medallion Wealth Advisors held 5 shares of West Pharmaceutical worth $1.85K as of Q3 2026.
- Medallion Wealth Advisors left its West Pharmaceutical share count unchanged in Q3 2026.
- West Pharmaceutical made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q3 2026, its #969 holding.
- Medallion Wealth Advisors first reported a position in West Pharmaceutical in Q4 2024 and has held it in 8 quarters since.
- Medallion Wealth Advisors's West Pharmaceutical position peaked at $35.2K in Q4 2025.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Medallion Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.